Evidence map›Paper›PMID 35596918›Full record

ArticleJournal of endocrinological investigation2022

Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m

J Ling, H Tang, H Meng, L Wu, L Zhu, S Zhu

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J Ling *Department of Metabolic and Bariatric Surgery, The Third Xiangya Hospital of Central South University, 138 Tongzipo Rd, Yuelu District, Changsha, 410013, China.ORCID http://orcid.org/0000-0002-9369-4886
H Tang *Department of Metabolic and Bariatric Surgery, The Third Xiangya Hospital of Central South University, 138 Tongzipo Rd, Yuelu District, Changsha, 410013, China.
H MengDepartment of General Surgery, The China-Japan Friendship Hospital, Beijing, China.
L WuDepartment of Metabolic Surgery, The Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
L ZhuDepartment of Metabolic and Bariatric Surgery, The Third Xiangya Hospital of Central South University, 138 Tongzipo Rd, Yuelu District, Changsha, 410013, China. zly8128@csu.edu.cn.
S ZhuDepartment of Metabolic and Bariatric Surgery, The Third Xiangya Hospital of Central South University, 138 Tongzipo Rd, Yuelu District, Changsha, 410013, China. shaihongzhu@126.com.
Central South University · CNChina-Japan Friendship Hospital · CNGuangzhou University of Chinese Medicine · CN

Funding

Guangdong Province Introduction of Innovative R&D Team 2018-RC-1Research and promotion of clinical characteristics and results in Capital Z151100004015065
6 · The paper itself

Abstract

backgroundRoux-en-Y gastric bypass (RYGB) has been widely reported to be safe and feasible, and has a powerful effect on improving metabolism and weight loss in patients with a high body mass index (BMI). A few studies have focused on the comparison of RYGB with medical treatment in type 2 diabetes (T2D) patients with a lower BMI.

objectivesTo compare the metabolic effects and safety of RYGB versus medical treatment during a 2 years follow-up in T2D patients with a BMI of 25 to 32.5 kg/m

methodsThis retrospective and multicenter cohort study participants were extracted from the T2D patients with a lower BMI (25-32.5 kg/m

resultsIn total, 213 patients (mean age of 47.4 ± 9.5 years, 70.4% male, mean BMI of 28.6 ± 2.2 kg/m

conclusionsAmong T2D patients with a BMI between 25.0 and 32.5 kg/m

Indexed as

Diabetes Mellitus, Type 2Gastric BypassObesity, MorbidAdultBody Mass IndexCohort StudiesFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesTreatment OutcomeWeight LossLow body mass indexMedical treatmentMetabolic surgeryObesityPropensity score matchingType 2 diabetes

Identifiers

PMID35596918
OpenAlexW4281251676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.